• About
    • Team
    • Company
    • Culture
    • Events
    • Hindustan Hamara
    • Jobs
  • Portfolio
  • Innovation Partner
  • Resources
  • News
  • CXXO
  • PITCH
  • About
    • Team
    • Company
    • Culture
    • Events
    • Hindustan Hamara
    • Jobs
  • Portfolio
  • Innovation Partner
  • Resources
  • News
  • CXXO
  • PITCH

  • Why We Invested in Studio Sirah

    25 January, 2023

  • Why We Invested in Peer Robotics

    3 January, 2023

  • Why We Invested in Tring

    29 November, 2022

  • A List Of SaaS Resources You’ll Want To Bookmark

    10 October, 2022

Follow Us

Innovation Driven

Clinical Stage Bio-Pharmaceutical Company

Vyome Therapeutics is an innovation-driven, clinical stage specialty pharmaceutical company, working to treat inflammatory diseases with locally-acting, next generation therapeutic solutions. Vyome’s management team members are leaders in the drug development field, with deep expertise and a proven track record of successfully launching over 50 products in the life sciences space, and in building visionary companies.

Website

Successful Clinical Trials 2B+

Patents Filed 300+

Partner Since Series A , 2012

Why Did Kalaari Invest in Vyome?

Vyome’s innovations are centered around the problems of skin and hair, which is a global market. ~75% of the world’s population is inflicted by skin disorders and dandruff problems.

However, the products available today are based on decades-old technologies. There is scope for developing products with much higher efficacy via the use of evolving technology like nanotechnology.

The company has an illustrious board and advisory panel with phenomenal accomplishments in the area of Lifesciences technology. In addition, the management team includes people who have spent decades at top Indian and global lifesciences and cosmeceutical outfits, giving them immense experience and understanding of the area.

Dr. Shiladitya Sengupta has been associated with founding various successful lifesciences companies in the past decade. His track record and network and access to technology at Harvard are a strong positive for the company.

In Venkat, the team also has a marketing brain behind launching various Birla Healthcare new initiatives and many years of experience heading a core skin-care brand such as Emami in India.
Read more

Sector: Enterprise, HealthTech
Status: Active
null
null

Founders

null

Venkateswarlu Nelabhotla

LinkedIn
null

Shiladitya Sengupta

LinkedIn

Kalaari Support

Related Content

Nothing Found

Subscribe to our Newsletter

    • CXXO
    • Portfolio
    • Innovation Partner
    • News

    About

    • Team
    • Company
    • Culture
    • Events
    • Hindustan Hamara
    • Resources
    • Contact Us
    • Pitch
    • Refer a Founder
    • +91-80-6715-9600
    • Connect with Us
    Designed by peppersquare

    © 2021 Kalaari Capital

    • Privacy Policy
    • Cookies Policy
    • Terms of Use

    Refer a Founder or a Startup

    Thank you for taking the time to refer a company/founder. Your recommendation adds value to our investment decision-making process.If you have any questions on whom/which company to recommend, please refer to our FAQ section.

    When you refer a founder/company, we are committed to assessing whether Kalaari can proceed with the investment and inform you of our decision. If we decide to invest in the referred founder/company, you are welcome to participate as an angel investor.